Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results

Harpoon Therapeutics, Inc. (HARP) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 4 Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 5,797 shares @ $0
10/02/2023 4 HUNT RONALD (10% Owner) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 3,035 shares @ $0
10/02/2023 4 Chin Mark (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 3,035 shares @ $0
07/06/2023 4 Chin Mark (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 18,656 shares @ $0
07/06/2023 4 HUNT RONALD (10% Owner) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 18,656 shares @ $0
07/06/2023 4 Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 35,634 shares @ $0
04/04/2023 4 Viney Joanne L. (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 21,028 shares @ $0
04/04/2023 4 Myers Scott Dunseth (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 34,925 shares @ $0
04/04/2023 4 HUNT RONALD (10% Owner) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 18,285 shares @ $0
04/04/2023 4 Colowick Alan (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 16,456 shares @ $0
04/04/2023 4 Chin Mark (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 18,285 shares @ $0
03/27/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/26/2023 4 Lanza Frank J (Principal Fin. & Acctng Ofc.) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 65,000 options to buy @ $0.89, valued at $57.9k
01/26/2023 4 Walker Luke Nathaniel (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $0.89, valued at $89k
01/26/2023 4 EASTLAND JULIA MARIE (President and CEO) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 407,600 options to buy @ $0.89, valued at $362.8k
11/29/2022 4 Lanza Frank J (Principal Fin. & Acctng Ofc.) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 86,438 options to buy @ $0.697, valued at $60.2k
10/04/2022 4 Walker Luke Nathaniel (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 305,000 options to buy @ $1.08, valued at $329.4k
10/04/2022 3 Walker Luke Nathaniel (Chief Medical Officer) has filed a Form 3 on Harpoon Therapeutics, Inc.
09/19/2022 3 Lanza Frank J (Principal Fin. & Acctng Ofc.) has filed a Form 3 on Harpoon Therapeutics, Inc.
09/19/2022 4 SILVERNAIL LAUREN P (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 20,335 options to buy @ $1.62, valued at $32.9k
09/19/2022 3 SILVERNAIL LAUREN P (Director) has filed a Form 3 on Harpoon Therapeutics, Inc.
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 BAILES JOSEPH S (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 10,167 options to buy @ $2.01, valued at $20.4k
Granted 31,428 options to buy @ $2.01, valued at $63.2k
02/01/2022 4 Wesche Holger (Chief Scientific Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 135,000 options to buy @ $5.03, valued at $679.1k
02/01/2022 4 Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 155,000 options to buy @ $5.03, valued at $779.7k
02/01/2022 4 Erbez Georgia (CFO) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 115,000 options to buy @ $5.03, valued at $578.5k
11/15/2021 4 Sacks Natalie (Chief Medical Officer) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 155,000 options to buy @ $7.73, valued at $1.2M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy